Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myrcene
- Development stage
- Phase 1
- Modality
- Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Topical, Inhalation
01
Overview
Myrcene is a naturally occurring monoterpene found abundantly in various plant species including hops, cannabis, lemongrass, thyme, and mangoes. It functions as a flavoring and aroma agent in food and beverages, and is also used in cosmetics, soaps, and detergents. Myrcene exhibits several biological properties including sedative, anti-inflammatory, analgesic, antioxidant, and antimicrobial effects.
- Other names
- β-myrcenebeta-myrcene7-methyl-3-methylene-1,6-octadiene2-methyl-6-methylene-2,7-octadiene3-methylene-7-methyl-1,6-octadiene
02
Targets
GABRR (GABA-A receptor subunit rho)TRPV1 (Transient receptor potential cation channel subfamily V member 1)GABA-B (Gamma-aminobutyric acid receptor type B)
Beyond the preview
Go deeper on myrcene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on myrcene.